Crusoe raised ~$3B at a $30B valuation, roughly tripling in 11 months, then signed a $13B AI cloud deal with trading firm Jane Street.
Revolution Medicines' RASONQUE is the first broad RAS-targeted pill for metastatic pancreatic cancer, nearly doubling median survival to 13.2 months. The catch: $39,800 a month.
Spanish startup iPronics raised a $125M Series B, with Nvidia participating, to swap copper for light and rewire AI data centers in sub-milliseconds.
Miami's Felix closed a $200M Series C led by a16z and General Catalyst at a ~$1.4B valuation, moving $8B in remittances for 6M+ users through a WhatsApp chat.
The Pentagon opened GenAI.mil to 3 million personnel with ChatGPT Mil and Grok for Government at IL5 clearance. Anthropic's Claude is the one vendor left out.
DeepSeek went out for about $7 billion and investors came back with at least $12 billion, in a Tencent- and CATL-led round ahead of a planned 2027 IPO.
🔥 Gigabyte Just Dropped a $400 WOLED Gaming Monitor and It Changes Everything...
The AI chip company Cerebras Systems — the most prominent challenger to Nvidia's GPU empire — hit the Nasdaq on Thursday under the ticker CBRS and...
> In 2025, startups discovered AI. In 2026, the winners figured out which tools to use and when. Here's the stack the smartest founders are runni...
Bending Spoons is buying Airtable for $1.285 billion in all cash — about 89% below the productivity startup's $11.7B pandemic-era peak, and its first deal since going public.
The FDA just approved FAYUVI, the first-ever treatment for Sanfilippo syndrome type A: a one-time gene therapy from Ultragenyx priced at $3.95 million per patient.
Adicet's off-the-shelf CAR-T put 54% of a small lupus trial into remission on a single dose. Then the stock dropped 22%.
Precision Neuroscience closed an oversubscribed $250M Series D at a ~$1B valuation, betting its surface brain implant beats drilling into tissue.
